doi: 10.3390/jpm13101443 197 KarachentsevYIKravchunNChernyaevaADunaevaIKholodnyAEfimenkoTet al
Safety Information Common Side Effects Common side effects may include nausea, constipation, diarrhea, fatigue, reduced appetite, bloating, or stomach discomfort
Is it possible we are missing a treatment effect of Lixisenatide because of the heterogeneity present in most Parkinsons groups recruited for clinical trials (in other words Parkinsons is not one disease and we may have recruited a few different subtypes and this watered down the potential effects)
Mistake 4: eating the same three meals on repeat Meal fatigue is real, especially when food is already unappealing
Importantly, NAD+ Injection is not an FDA-approved drug
After the first month on any GLP-1 treatment, patients can add the Precision Peptide Genetic Test ($99) to understand their individual peptide pathway genetics, revealing which combination of hormone therapiestestosterone, GLP-1, or bothwill likely yield the strongest metabolic response based on their GIPR, GLP1R, FTO, and MC4R variants